Scottish Medicines Consortium

This page shows the latest Scottish Medicines Consortium news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: DeepMind and NHS success in AI eyecare, Bayer invests in COPD, Alecensa OK in Scotland

Roche’s Alecensa approved by Scottish Medicines Consortium. Patients in Scotland with untreated, advanced non-small-cell lung cancer (NSCLC) with ALK-positive tumours have a new treatment option available via ... The positive decision from the Scottish

Latest news

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

EUSA’s Fotivda approved for NHS use in Scotland. Specialist pharma company EUSA Pharma has welcomed the Scottish Medicines Consortium approval of its renal cell carcinoma treatment Fotivda (tivozanib).
UK, Germany back routine use of J&J’s Tremfya

The National Institute for Health and Care Excellence (NICE) for England and Wales, the Scottish Medicines Consortium (SMC) and Germany’s Federal Joint Committee (G-BA) are the first health technology
Merck and Pfizer set to win NICE backing for Bavencio

The pharma giants are expecting final guidance from NICE within the next coming weeks, and a decision by the Scottish Medicines Consortium (SMC) is also expected.
NICE reverses its rejection of Eisai’s Lenvima

This particular subset of patients in Scotland and Wales can already access Eisai’s medicine due to approvals from the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy. ... The positive recommendation comes three years after the
NICE backs Roche’s Gazyvaro after initial rejection

The Scottish Medicines Consortium (SMC) turned down Gazyvaro as a first-line option with chemotherapy last month.

More from news
Approximately 4 fully matching, plus 88 partially matching documents found.

Latest Intelligence

The reality of real-world evidence

Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

New Business Director - PR: Competitive Salary and benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Associate Director, Market Access & HEOR – North-West: Negotiable

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Director, Market Access / HEOR - North-West: Negotiable

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Consumer Health Account Director: Circa £60, 000 Gym and More

Events Manager – Med Comms – Surrey: Salary TBC

Medical Writers: Competitive Salary and Benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Senior Account Manager: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Medical Writer: Competitive Salary

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Account Executive, London, Medical Communications: Excellent package

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Associate Editorial Director – Med Comms – London: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Associate Medical Director: Highly Competitive

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health: For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...